122883-93-6 | 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one hydrochloride

Packsize	Purity	Availability	Price	Discounted Price
5mg	99%(HPLC)	in stock	$53.00	$37.00
50mg	≥98%	in stock	$92.00	$65.00
250mg	≥98%	in stock	$316.00	$221.00
1g	97%	in stock	$387.00	$271.00
5g	97%	in stock	$1,226.00	$858.00

Description

• Catalog Number: AA25307
• Chemical Name: 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one hydrochloride
• CAS Number: 122883-93-6
• Molecular Formula: C21H22Cl2N4OS
• Molecular Weight: 449.3966
• MDL Number: MFCD00921885
• SMILES: O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2.Cl

Computed Properties

• Complexity: 573
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 29
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4

Literature

• Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol S-methyltransferase in humans: an in vitro study.

  Xenobiotica; the fate of foreign compounds in biological systems 20121101

• Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• A case of severe hyponatremia induced by duloxetine and ziprasidone.

  Chinese medical journal 20121001

• Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics.

  Experimental & molecular medicine 20120930

• Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.

  Journal of psychopharmacology (Oxford, England) 20120901

• Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.

  Expert opinion on drug safety 20120901

• Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?

  Journal of clinical psychopharmacology 20120801

• Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.

  Schizophrenia bulletin 20120701

• Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.

  Pharmacopsychiatry 20120701

• Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.

  International clinical psychopharmacology 20120701

• Single-dose ziprasidone associated with QT interval prolongation.

  The American journal of emergency medicine 20120601

• The effect of ziprasidone on body weight and energy expenditure in female rats.

  Metabolism: clinical and experimental 20120601

• Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state.

  Pharmacopsychiatry 20120601

• Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.

  The Journal of clinical psychiatry 20120601

• In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.

  International journal of pharmaceutics 20120530

• Network-assisted investigation of antipsychotic drugs and their targets.

  Chemistry & biodiversity 20120501

• The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.

  The Journal of clinical psychiatry 20120401

• Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.

  CNS drugs 20120401

• Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).

  Cutis 20120401

• Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.

  European child & adolescent psychiatry 20120301

• Serum prolactin levels and the acute-phase efficacy in drug-naïve schizophrenia treated with ziprasidone and olanzapine (translated version).

  East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan 20120301

• Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201

• The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.

  Psychopharmacology 20120201

• Antipsychotic-induced psychotic-like syndrome and pathological smiling in an adolescent.

  Journal of child and adolescent psychopharmacology 20120201

• Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents.

  Schizophrenia bulletin 20120101

• Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.

  Human psychopharmacology 20120101

• Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.

  Clinical schizophrenia & related psychoses 20120101

• Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.

  Clinical neuropharmacology 20120101

• A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.

  PloS one 20120101

• Three key antipsychotics lose patent protection.

  Behavioral healthcare 20120101

• High-performance liquid chromatographic assay for ziprasidone in plasma samples: application to pharmacokinetic studies in rats.

  Journal of chromatographic science 20120101

• The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder.

  The Israel journal of psychiatry and related sciences 20120101

• Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.

  Pharmacological reports : PR 20120101

• Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.

  BMC psychiatry 20120101

• Development of rapid and robust stability-indicating method for analysis of ziprasidone (hydrochloride and freebase) as drug substance and in medicines by UPLC.

  Acta poloniae pharmaceutica 20120101

• Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.

  Biomedical chromatography : BMC 20111201

• Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.

  Pharmaceutical research 20111201

• Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.

  Xenobiotica; the fate of foreign compounds in biological systems 20111201

• Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.

  Clinical therapeutics 20111201

• Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.

  Journal of clinical pharmacology 20111101

• Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC).

  Pharmacoepidemiology and drug safety 20111101

• Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.

  Schizophrenia research 20111101

• Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20111001

• Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.

  Expert opinion on pharmacotherapy 20111001

• Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.

  Journal of clinical psychopharmacology 20111001

• Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study.

  The international journal of neuropsychopharmacology 20110901

• Ziprasidone induced symptomatic bradycardia: a case report.

  The Australian and New Zealand journal of psychiatry 20110901

• Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.

  Pharmacotherapy 20110901

• Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.

  Journal of psychiatric research 20110801

• Outcome assessment of an antipsychotic drug algorithm: effects of the Mississippi State Hospital algorithm project.

  Psychiatric services (Washington, D.C.) 20110801

• Digital Holter measurement of QT prolongation in ziprasidone overdose.

  Clinical toxicology (Philadelphia, Pa.) 20110801

• Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes.

  Journal of psychopharmacology (Oxford, England) 20110701

• Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.

  American journal of therapeutics 20110701

• Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy.

  Journal of pharmaceutical sciences 20110701

• Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.

  Journal of pharmaceutical sciences 20110701

• Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.

  Journal of fluorescence 20110701

• Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.

  Pharmacopsychiatry 20110701

• Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).

  The Journal of clinical psychiatry 20110701

• Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.

  Journal of psychopharmacology (Oxford, England) 20110601

• QT interval duration and dispersion in children and adolescents treated with ziprasidone.

  The Journal of clinical psychiatry 20110601

• Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.

  The American journal of psychiatry 20110601

• Drug safety evaluation of ziprasidone.

  Expert opinion on drug safety 20110501

• The safety of atypical antipsychotics: does QTc provide all the answers?

  Expert opinion on drug safety 20110501

• Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.

  Neuroscience research 20110401

• Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.

  Schizophrenia research 20110401

• Ziprasidone for maintenance treatment of bipolar I disorder in adults.

  Expert opinion on pharmacotherapy 20110401

• Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20110330

• Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.

  Schizophrenia bulletin 20110301

• Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

  The Journal of clinical psychiatry 20110301

• Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data.

  Schizophrenia research 20110301

• Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.

  Journal of psychiatric practice 20110301

• Use of ziprasidone in patients with schizophrenia in four European countries.

  European psychiatry : the journal of the Association of European Psychiatrists 20110301

• Switching among antipsychotics--focus on side effects.

  Psychiatria Danubina 20110301

• Antipsychotic treatment--side-effect and/or metabolic syndrome.

  Psychiatria Danubina 20110301

• Weight gain--as possible predictor of metabolic syndrome.

  Psychiatria Danubina 20110301

• Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.

  The Journal of clinical psychiatry 20110301

• Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20110301

• Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.

  Expert review of clinical pharmacology 20110301

• Third degree heart block following intramuscular ziprasidone.

  Schizophrenia research 20110201

• Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).

  The American journal of psychiatry 20110201

• Ziprasidone and the relative risk of diabetes.

  The British journal of psychiatry : the journal of mental science 20110201

• What can large simple trials do for psychiatry?

  The American journal of psychiatry 20110201

• Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.

  Behavioural brain research 20110120

• Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

  Molecular psychiatry 20110101

• Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.

  Biological research for nursing 20110101

• A thermodynamic-based approach to analyzing a highly solvating polymorphic system: the desolvation window method.

  Journal of pharmaceutical sciences 20110101

• Differential effects of ziprasidone and haloperidol on immobilization-stress-induced CRF mRNA expression in the hypothalamic paraventricular nucleus of rats.

  Neuropsychobiology 20110101

• Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110101

• Risperidone versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20110101

• Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.

  Postgraduate medicine 20110101

• Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) or Hashimoto's encephalopathy: a case and review.

  Psychosomatics 20110101

• Development and validation of an HPLC method for determination of ziprasidone and its impurities in pharmaceutical dosage forms.

  Journal of AOAC International 20110101

• Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.

  BMC psychiatry 20110101

• Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures.

  Neuropsychobiology 20110101

• Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.

  The Israel journal of psychiatry and related sciences 20110101

• Use of a new ziprasidone-selective electrode in mixed solvents and its application in the analysis of pharmaceuticals and biological fluids.

  Sensors (Basel, Switzerland) 20110101

• Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.

  Neuro endocrinology letters 20110101

• Pediatric ziprasidone ingestions.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201

• Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101201

• A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.

  Journal of clinical psychopharmacology 20101201

• Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.

  Journal of clinical psychopharmacology 20101201

• Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

  Schizophrenia research 20101101

• Bitter pills for drug companies.

  BMJ (Clinical research ed.) 20100917

• Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.

  European journal of clinical pharmacology 20100901

• Strategies for successful clinical management of schizophrenia with ziprasidone.

  Expert opinion on pharmacotherapy 20100901

• Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.

  Pharmacotherapy 20100901

• The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.

  Clinics (Sao Paulo, Brazil) 20100901

• Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

  Journal of clinical psychopharmacology 20100801

• Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.

  Pharmacopsychiatry 20100801

• Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.

  Journal of clinical psychopharmacology 20100801

• Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial?

  Journal of clinical psychopharmacology 20100801

• Characteristics and mortality among hospitalized patients treated with intramuscular antipsychotics: analysis of a United States hospital database.

  Current drug safety 20100702

• Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.

  Schizophrenia research 20100701

• Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.

  Expert review of neurotherapeutics 20100701

• Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine.

  Human psychopharmacology 20100701

• Electroanalytical characteristics of antipsychotic drug ziprasidone and its determination in pharmaceuticals and serum samples on solid electrodes.

  Talanta 20100630

• Ziprasidone-induced spontaneous orgasm.

  Journal of psychopharmacology (Oxford, England) 20100601

• Safety of the electroconvulsive therapy-ziprasidone combination.

  The journal of ECT 20100601

• Serotonin syndrome caused by ziprasidone alone.

  Psychiatry and clinical neurosciences 20100601

• [Descriptive analysis of the use of atypical antipsychotics under compassionate-use in a health area in Ferrol (La Coruña, Spain)].

  Neurologia (Barcelona, Spain) 20100601

• Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100501

• Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.

  Clinical neuropharmacology 20100501

• Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.

  Journal of psychopharmacology (Oxford, England) 20100401

• Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.

  Journal of affective disorders 20100401

• Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.

  The Annals of pharmacotherapy 20100401

• Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.

  Journal of clinical psychopharmacology 20100401

• A nearly overlooked mild case of ziprasidone-induced lingual dystonia.

  Journal of clinical psychopharmacology 20100401

• Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.

  Biochemical and biophysical research communications 20100305

• Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.

  Journal of psychopharmacology (Oxford, England) 20100301

• Pediatric uptake of a newly available antipsychotic medication.

  Pediatrics 20100301

• Respiratory failure following isolated ziprasidone ingestion in a toddler.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20100301

• Ziprasidone as a possible cause of cleft palate in a newborn.

  Psychiatria Danubina 20100301

• Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.

  Clinical therapeutics 20100301

• Antipsychotics in pregnancy.

  Journal of psychiatric and mental health nursing 20100301

• How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.

  Journal of psychiatric practice 20100301

• Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.

  Psychiatry research 20100227

• Torsade de pointes after ziprasidone overdose with coingestants.

  Journal of clinical psychopharmacology 20100201

• Free your MIND and the rest will follow: decoding delirium in the intensive care unit.

  Critical care medicine 20100201

• Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.

  Critical care medicine 20100201

• Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.

  Pharmacotherapy 20100201

• Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.

  The Journal of clinical psychiatry 20100201

• Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.

  Psychiatric services (Washington, D.C.) 20100201

• Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.

  Journal of psychiatric research 20100101

• Amisulpride versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• Quetiapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• The successful treatment of mania due to acquired immunodeficiency syndrome using ziprasidone: a case series.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Olanzapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.

  BMC psychiatry 20100101

• A possible case of mixed mania due to neurosarcoidosis treated successfully with methylprednisolone and ziprasidone: another example of frontal-subcortical disinhibition?

  General hospital psychiatry 20100101

• Clozapine versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20100101

• [Practical aspects of the use of ziprasidone in schizophrenia].

  Psychiatria polska 20100101

• Ziprasidone-related oculogyric crisis in an adult.

  Clinical neurology and neurosurgery 20091201

• Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.

  Schizophrenia research 20091201

• Vocal tics associated with ziprasidone.

  Journal of clinical psychopharmacology 20091201

• Brugada syndrome unmasked by lithium.

  Southern medical journal 20091201

• Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.

  Journal of child and adolescent psychopharmacology 20091201

• Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.

  Behavioural brain research 20091105

• Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.

  Molecular psychiatry 20091101

• The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.

  Journal of psychopharmacology (Oxford, England) 20091101

• Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol.

  Schizophrenia research 20091101

• Ziprasidone monotherapy in bipolar II depression: an open trial.

  Journal of affective disorders 20091101

• P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration.

  Pharmacological research 20091101

• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.

  The American journal of psychiatry 20091101

• Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.

  The international journal of neuropsychopharmacology 20091001

• The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

  Pharmacoepidemiology and drug safety 20090901

• Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.

  International clinical psychopharmacology 20090901

• Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone--a claims database approach.

  Pharmacoepidemiology and drug safety 20090901

• Pregnancy and atypical antipsychotics.

  Psychiatria Danubina 20090901

• Activation induced by high-dose ziprasidone: a case report.

  The Journal of clinical psychiatry 20090901

• Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies.

  CNS spectrums 20090901

• FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.

  JAMA 20090826

• Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.

  Molecular psychiatry 20090801

• Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.

  Schizophrenia research 20090801

• Using oral ziprasidone effectively: the food effect and dose-response.

  Advances in therapy 20090801

• [Pharmacokinetics and relative bioavailability of ziprasidone tablets in Chinese healthy volunteers].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090801

• In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.

  Journal of psychiatric research 20090701

• Unintentional ingestion of ziprasidone in a 22-month-old.

  Pediatric emergency care 20090701

• How dosing of ziprasidone in a state hospital system differs from product labeling.

  The Journal of clinical psychiatry 20090701

• Ziprasidone-induced angioedema: a case report.

  The Journal of clinical psychiatry 20090701

• Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.

  Schizophrenia research 20090601

• Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.

  Journal of neurosurgery. Pediatrics 20090601

• Targeting cognition in schizophrenia research: from etiology to treatment.

  The American journal of psychiatry 20090601

• A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

  The American journal of emergency medicine 20090601

• Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.

  Journal of medical economics 20090601

• Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.

  The Journal of clinical psychiatry 20090601

• Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.

  The Journal of clinical psychiatry 20090601

• Atypical antipsychotic drugs and the risk of sudden cardiac death.

  The New England journal of medicine 20090514

• Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.

  Journal of psychopharmacology (Oxford, England) 20090501

• Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.

  Schizophrenia research 20090501

• Weight effects associated with antipsychotics: a comprehensive database analysis.

  Schizophrenia research 20090501

• Akathisia and second-generation antipsychotic drugs.

  Current opinion in psychiatry 20090501

• Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20090430

• Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.

  The Journal of clinical psychiatry 20090421

• The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey.

  European psychiatry : the journal of the Association of European Psychiatrists 20090401

• Low concentration of ziprasidone in human milk: a case report.

  The international journal of neuropsychopharmacology 20090401

• Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.

  Human psychopharmacology 20090401

• How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.

  European psychiatry : the journal of the Association of European Psychiatrists 20090401

• Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.

  The Journal of clinical psychiatry 20090401

• Pediatric ziprasidone overdose.

  Pediatric emergency care 20090401

• A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.

  Community mental health journal 20090201

• Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats.

  Journal of psychiatric research 20090101

• Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial.

  The Journal of clinical psychiatry 20090101

• A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20090101

• Extrapyramidal side effects: could you identify them in the emergency department?

  Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20090101

• Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.

  BMC psychiatry 20090101

• Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.

  The Cochrane database of systematic reviews 20090101

• The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia.

  Clinical neuropharmacology 20090101

• Tardive dyskinesia in a patient treated with quetiapine.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• A failed case of weaning from a mechanical ventilator with lorazepam successfully accomplished by ziprasidone.

  General hospital psychiatry 20090101

• Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone).

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101

• Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.

  Psychopharmacology bulletin 20090101

• Ziprasidone versus other atypical antipsychotics for schizophrenia.

  The Cochrane database of systematic reviews 20090101

• New-onset vascular mania in a patient with chronic depression.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• Ziprasidone induced tardive cervical dystonia.

  Psychopharmacology bulletin 20090101

• Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.

  Therapeutic drug monitoring 20081201

• Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

  Journal of clinical psychopharmacology 20081201

• Ziprasidone-associated mania in Korean schizophrenic patient.

  Journal of clinical psychopharmacology 20081201

• The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.

  Bipolar disorders 20081201

• A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.

  Schizophrenia research 20081001

• Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.

  Journal of clinical psychopharmacology 20081001

• Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.

  Journal of child and adolescent psychopharmacology 20081001

• Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.

  Psychiatry and clinical neurosciences 20081001

• Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia.

  CNS spectrums 20081001

• Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.

  Brain research bulletin 20080930

• The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.

  European journal of pharmacology 20080911

• Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

  Schizophrenia research 20080801

• Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.

  Progress in neuro-psychopharmacology & biological psychiatry 20080801

• Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.

  Journal of psychopharmacology (Oxford, England) 20080701

• Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.

  Biomedical chromatography : BMC 20080701

• Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.

  Schizophrenia research 20080701

• Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.

  International clinical psychopharmacology 20080701

• Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.

  The Journal of clinical psychiatry 20080701

• Profound hypothermia secondary to normal ziprasidone use.

  The American journal of emergency medicine 20080701

• Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080601

• Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.

  The Annals of pharmacotherapy 20080601

• Clinical experiences and clinical trials.

  CNS spectrums 20080601

• Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

  Human & experimental toxicology 20080601

• Did CATIE influence antipsychotic use?

  Psychiatric services (Washington, D.C.) 20080501

• What CATIE found: results from the schizophrenia trial.

  Psychiatric services (Washington, D.C.) 20080501

• Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080401

• Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.

  Acta psychiatrica Scandinavica 20080401

• Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.

  The Journal of clinical psychiatry 20080401

• Ziprasidone-induced hyperprolactinemia: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.

  Journal of clinical psychopharmacology 20080401

• High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.

  Journal of clinical psychopharmacology 20080401

• [Ziprasidone in Parkinsonian dopamine psychosis].

  Revista de neurologia 20080401

• Problems with CATIE. Phase 1: Looking back--what the clinician needs to know.

  Connecticut medicine 20080401

• Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005.

  Human & experimental toxicology 20080401

• Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

  Lancet (London, England) 20080329

• Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation.

  Behavioural brain research 20080305

• Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.

  Journal of psychopharmacology (Oxford, England) 20080301

• Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat.

  Behavioural pharmacology 20080301

• Urinary retention associated with ziprasidone: a case report.

  The Journal of clinical psychiatry 20080301

• Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Determination of Ziprasidone in pharmaceutical formulations by capillary zone electrophoresis.

  Journal of pharmaceutical and biomedical analysis 20080213

• A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.

  The Journal of clinical psychiatry 20080201

• Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.

  Schizophrenia research 20080101

• The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma.

  Progress in neuro-psychopharmacology & biological psychiatry 20080101

• Use of antipsychotics to treat cocaine toxicity?

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20080101

• Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.

  Journal of psychiatric practice 20080101

• Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.

  The Journal of neuropsychiatry and clinical neurosciences 20080101

• The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.

  The Journal of clinical psychiatry 20080101

• The use of atypical antipsychotics after traumatic brain injury.

  The Journal of head trauma rehabilitation 20080101

• Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.

  Psychotherapy and psychosomatics 20080101

• Ziprasidone-induced tardive laryngeal dystonia: a case report.

  General hospital psychiatry 20080101

• The use of atypical antipsychotics in pediatric bipolar disorder.

  The Journal of clinical psychiatry 20080101

• Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

  The Journal of clinical psychiatry 20080101

• Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.

  The Journal of clinical psychiatry 20080101

• Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study.

  Clinical drug investigation 20080101

• Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.

  Clinical neuropharmacology 20080101

• Ziprasidone in the treatment of affective disorders: a review.

  CNS neuroscience & therapeutics 20080101

• A possible case of Capgras syndrome after a right anterior cerebral artery cerebrovascular accident treated successfully with mirtazapine.

  The Journal of neuropsychiatry and clinical neurosciences 20080101

• Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists.

  Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20071201

• Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.

  Journal of clinical psychopharmacology 20071201

• QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20071201

• A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder.

  Bipolar disorders 20071201

• Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.

  The Journal of clinical psychiatry 20071201

• Ziprasidone in adolescents with autism: an open-label pilot study.

  Journal of child and adolescent psychopharmacology 20071201

• Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.

  International clinical psychopharmacology 20071101

• Clinical relevance of relative receptor binding affinity: quetiapine and ziprasidone as examples.

  Journal of psychiatric practice 20071101

• Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

  The American journal of managed care 20071101

• Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

• The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

  Psychopharmacology 20071001

• The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats.

  British journal of pharmacology 20071001

• Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.

  Journal of clinical psychopharmacology 20071001

• Managing the acutely agitated and psychotic patient.

  CNS spectrums 20071001

• Practical strategies for assessing and stabilizing bipolar patients in urgent situations.

  The Journal of clinical psychiatry 20071001

• Show me the evidence: using number needed to treat.

  Southern medical journal 20070901

• Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.

  The Journal of clinical psychiatry 20070901

• The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.

  Schizophrenia research 20070801

• Impairment in error monitoring predicts poor executive function in schizophrenia patients.

  Schizophrenia research 20070801

• Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model.

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20070801

• Metabolic effects of the atypical antipsychotics.

  Southern medical journal 20070801

• A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.

  Journal of child and adolescent psychopharmacology 20070801

• Ziprasidone-associated mania in a case of obssessive-compulsive disorder.

  CNS spectrums 20070801

• Possible case of allopurinol causing relapse of psychosis.

  Schizophrenia research 20070701

• Urticaria and angio-oedema due to ziprasidone.

  Journal of psychopharmacology (Oxford, England) 20070701

• Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.

  The Journal of clinical psychiatry 20070701

• Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.

  Molecular psychiatry 20070601

• Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.

  Bone marrow transplantation 20070601

• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  Archives of general psychiatry 20070601

• A different mechanism to understand activation/sedation side effects of ziprasidone.

  The Journal of clinical psychiatry 20070601

• Ziprasidone-induced acute laryngeal dystonia.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.

  Bipolar disorders 20070501

• Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.

  Pharmacopsychiatry 20070501

• Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial.

  European psychiatry : the journal of the Association of European Psychiatrists 20070401

• Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.

  Journal of clinical psychopharmacology 20070401

• Ziprasidone-associated galactorrhea in an adolescent female.

  Journal of child and adolescent psychopharmacology 20070401

• Ziprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorder.

  Journal of child and adolescent psychopharmacology 20070401

• High-dose ziprasidone-induced acute dystonia.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Use of ziprasidone in patients with fibromyalgia: a case series.

  Rheumatology international 20070301

• Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301

• Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

  The American journal of psychiatry 20070301

• Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

  The international journal of neuropsychopharmacology 20070201

• Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.

  Clinical neurology and neurosurgery 20070201

• Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.

  The Journal of the Association of Physicians of India 20070201

• Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

  Schizophrenia research 20070101

• Datapoints: The ups and downs of dosing second-generation antipsychotics.

  Psychiatric services (Washington, D.C.) 20070101

• A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070101

• Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.

  Clinical neuropharmacology 20070101

• Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report.

  Psychopharmacology bulletin 20070101

• Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia.

  Behavioural neurology 20070101

• Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101

• 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.

  Clinical and experimental pharmacology & physiology 20070101

• Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101

• Cocaine use as a risk factor for ziprasidone-induced acute dystonia.

  General hospital psychiatry 20070101

• Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.

  Journal of the American Pharmacists Association : JAPhA 20070101

• Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS).

  Actas espanolas de psiquiatria 20070101

• Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

  CNS drug reviews 20070101

• Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial.

  Clinical drug investigation 20070101

• Ziprasidone security in overdose: one case report.

  Actas espanolas de psiquiatria 20070101

• Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.

  CNS drugs 20070101

• Prospective observational multi-poison center study of ziprasidone exposures.

  Clinical toxicology (Philadelphia, Pa.) 20070101

• The effect of food on the absorption of oral ziprasidone.

  Psychopharmacology bulletin 20070101

• A case report with ziprasidone-induced catatonic symptoms.

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• Ziprasidone-associated depressive state in schizophrenic patients.

  Clinical neuropharmacology 20070101

• Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.

  The National medical journal of India 20070101

• A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20061230

• Ziprasidone in the treatment of Parkinson's disease psychosis.

  European psychiatry : the journal of the Association of European Psychiatrists 20061201

• Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia.

  The international journal of neuropsychopharmacology 20061201

• A model of anticholinergic activity of atypical antipsychotic medications.

  Schizophrenia research 20061201

• Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

  Journal of clinical psychopharmacology 20061201

• Treatment of psychosis: 30 years of progress.

  Journal of clinical pharmacy and therapeutics 20061201

• A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.

  Journal of child and adolescent psychopharmacology 20061201

• [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20061201

• Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics.

  Psychiatry research 20061115

• Early changes of plasma lipids during treatment with atypical antipsychotics.

  International clinical psychopharmacology 20061101

• Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?

  Schizophrenia research 20061001

• Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901

• A model for antipsychotic-induced obesity in the male rat.

  Psychopharmacology 20060901

• Probable association between ziprasidone and worsening hypertension.

  Pharmacotherapy 20060901

• The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.

  The Journal of clinical psychiatry 20060901

• Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats.

  The Journal of pharmacology and experimental therapeutics 20060801

• The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

  Psychopharmacology 20060801

• Long-term use of atypical antipsychotics in bipolar disorder.

  Pharmacotherapy 20060801

• Ziprasidone: efficacy and safety in patients with bipolar disorder.

  Expert review of neurotherapeutics 20060801

• Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

  CNS & neurological disorders drug targets 20060801

• Advanced pediatric psychopharmacology.

  Journal of child and adolescent psychopharmacology 20060801

• Ziprasidone-associated pedal edema in the treatment of schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20060701

• Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060701

• Acute dystonia after initial doses of ziprasidone: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• Ziprasidone in the treatment of delayed carbon monoxide encephalopathy.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

  Pharmacotherapy 20060601

• Electrocardiographic changes with ziprasidone.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060601

• Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060601

• Ziprasidone in bipolar disorder.

  Expert opinion on pharmacotherapy 20060601

• Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

  International clinical psychopharmacology 20060501

• Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.

  Behavioural pharmacology 20060501

• Injectable atypical antipsychotics for agitation in borderline personality disorder.

  Pharmacopsychiatry 20060501

• Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma.

  Biomedical chromatography : BMC 20060401

• Effect of initial ziprasidone dose on length of therapy in schizophrenia.

  Schizophrenia research 20060401

• Effect of initial ziprasidone dose on treatment persistence in schizophrenia.

  Schizophrenia research 20060401

• Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

  The American journal of psychiatry 20060401

• Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

  The American journal of psychiatry 20060401

• A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.

  Journal of clinical psychopharmacology 20060401

• Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

  The Journal of clinical psychiatry 20060401

• Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.

  The Journal of clinical psychiatry 20060401

• Intramuscular ziprasidone: an effective agent for sedation of the agitated ED patient.

  The American journal of emergency medicine 20060301

• Sudden akathisia after a ziprasidone dose reduction.

  The American journal of psychiatry 20060301

• Prescribing behavior and marketing practices.

  Psychiatric services (Washington, D.C.) 20060301

• Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.

  The Journal of nervous and mental disease 20060301

• Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.

  The Journal of clinical psychiatry 20060201

• Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.

  The Journal of clinical psychiatry 20060201

• Antipsychotic drugs and schizophrenia.

  The New England journal of medicine 20060119

• Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.

  Biochemical pharmacology 20060112

• Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia.

  International clinical psychopharmacology 20060101

• Urinary hesitancy and retention caused by ziprasidone.

  International clinical psychopharmacology 20060101

• The effects of ziprasidone on regional c-Fos expression in the rat forebrain.

  Psychopharmacology 20060101

• Ziprasidone- and lithium-induced neuroleptic malignant syndrome.

  The Annals of pharmacotherapy 20060101

• Ziprasidone-induced priapism requiring surgical treatment.

  European psychiatry : the journal of the Association of European Psychiatrists 20060101

• Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia.

  General hospital psychiatry 20060101

• Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.

  Psychiatric services (Washington, D.C.) 20060101

• Interpreting the results of the CATIE study.

  Psychiatric services (Washington, D.C.) 20060101

• Interpreting the results of the CATIE study.

  Psychiatric services (Washington, D.C.) 20060101

• Interpreting the results of the CATIE study.

  Psychiatric services (Washington, D.C.) 20060101

• Real-life switching strategies with second-generation antipsychotics.

  The Journal of clinical psychiatry 20060101

• Methodological issues in a comparative study of ziprasidone and risperidone.

  The Journal of clinical psychiatry 20060101

• A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania.

  European psychiatry : the journal of the Association of European Psychiatrists 20060101

• Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.

  The American journal on addictions 20060101

• Torsades de pointes associated with ziprasidone.

  Psychosomatics 20060101

• Self-mutilation of fingers after cervical spinal cord injury.

  Psychosomatics 20060101

• Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].

  Actas espanolas de psiquiatria 20060101

• An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.

  Dementia and geriatric cognitive disorders 20060101

• Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.

  CNS drugs 20060101

• Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.

  Clinical drug investigation 20060101

• The bane of a silent illness: when Wilson's disease takes its course.

  International journal of psychiatry in medicine 20060101

• An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.

  Toxicology 20051215

• Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.

  Neuropharmacology 20051201

• Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

  International psychogeriatrics 20051201

• Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20051201

• Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.

  Journal of clinical psychopharmacology 20051201

• Parkinsonism with intramuscular ziprasidone.

  The American journal of psychiatry 20051201

• Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.

  The American journal of geriatric pharmacotherapy 20051201

• Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20051123

• Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review.

  Pharmacotherapy 20051101

• Tardive dystonia associated with ziprasidone.

  The American journal of psychiatry 20051101

• Ziprasidone therapy for post-traumatic stress disorder.

  Journal of psychiatry & neuroscience : JPN 20051101

• From clinical research to clinical practice: a 4-year review of ziprasidone.

  CNS spectrums 20051101

• Applying parsimony to 'An African patient with ziprasidone intolerance'.

  The Journal of clinical psychiatry 20051101

• Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone.

  The Annals of pharmacotherapy 20051001

• Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.

  Journal of clinical psychopharmacology 20051001

• Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series.

  Cephalalgia : an international journal of headache 20051001

• Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.

  The American journal of psychiatry 20051001

• Atypical antipsychotics: special formulations for acute agitation.

  Journal of psychosocial nursing and mental health services 20051001

• Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051001

• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  The New England journal of medicine 20050922

• Ziprasidone decreases cortisol excretion in healthy subjects.

  British journal of clinical pharmacology 20050901

• Best clinical practice with ziprasidone IM: update after 2 years of experience.

  CNS spectrums 20050901

• Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050901

• Atypical antipsychotics in the management of delirium: a review of the empirical literature.

  Palliative & supportive care 20050901

• Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.

  Journal of clinical psychopharmacology 20050801

• Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.

  International journal of geriatric psychiatry 20050801

• Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.

  The American journal of psychiatry 20050801

• Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.

  The Journal of clinical psychiatry 20050801

• Ziprasidone and hypomania.

  CNS spectrums 20050801

• Ziprasidone-induced tardive dyskinesia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050801

• Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization.

  Drug metabolism and disposition: the biological fate of chemicals 20050701

• The highest intentional ziprasidone overdose was not fatal.

  Acta psychiatrica Scandinavica 20050701

• Cerebral cortical gray expansion associated with two second-generation antipsychotics.

  Biological psychiatry 20050701

• Methodological concerns in a trial of ziprasidone and olanzapine.

  The American journal of psychiatry 20050701

• Methodological concerns in a trial of ziprasidone and olanzapine.

  The American journal of psychiatry 20050701

• A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

  The Journal of clinical psychiatry 20050701

• Three-year experience with ziprasidone exposures.

  The American journal of emergency medicine 20050701

• Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

  Pharmacoepidemiology and drug safety 20050601

• Antipsychotic drug-induced weight gain: development of an animal model.

  International journal of obesity (2005) 20050601

• Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.

  Journal of clinical pharmacology 20050601

• An African patient with ziprasidone intolerance.

  The Journal of clinical psychiatry 20050601

• Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.

  Drug metabolism and pharmacokinetics 20050601

• The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.

  Neuro endocrinology letters 20050601

• Bipolar disorder.

  Clinical evidence 20050601

• Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.

  Behavioural brain research 20050528

• FDA warns antipsychotic drugs may be risky for elderly.

  JAMA 20050525

• Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.

  Brain research 20050510

• Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model.

  Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20050501

• Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.

  Psychopharmacology 20050401

• Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection.

  Therapeutic drug monitoring 20050401

• Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?

  Human psychopharmacology 20050401

• Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?

  Current opinion in pediatrics 20050401

• Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.

  Journal of psychopharmacology (Oxford, England) 20050301

• Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine.

  International clinical psychopharmacology 20050301

• D2-blockade and possible ziprasidone-induced galactorrhea.

  International clinical psychopharmacology 20050301

• Ziprasidone-induced acute dystonia.

  The American journal of psychiatry 20050301

• Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders.

  CNS spectrums 20050301

• The treatment of mixed states and the risk of switching to depression.

  European psychiatry : the journal of the Association of European Psychiatrists 20050301

• Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

  Psychopharmacology 20050201

• New onset of diabetes mellitus with ziprasidone: a case report.

  The Journal of clinical psychiatry 20050201

• Ziprasidone-induced galactorrhea: a case report.

  Neuro endocrinology letters 20050201

• Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.

  Expert opinion on pharmacotherapy 20050201

• Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20050101

• Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.

  Progress in neuro-psychopharmacology & biological psychiatry 20050101

• Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.

  General hospital psychiatry 20050101

• Blood dyscrasia with quetiapine and ziprasidone.

  Psychosomatics 20050101

• Ziprasidone-associated mania: a review and report of 2 additional cases.

  Clinical neuropharmacology 20050101

• 12,800-mg ziprasidone overdose without significant ECG changes.

  General hospital psychiatry 20050101

• Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.

  General hospital psychiatry 20050101

• The dosing of atypical antipsychotics.

  Psychosomatics 20050101

• Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current.

  Journal of pharmacological and toxicological methods 20050101

• Atypical antipsychotics: newer options for mania and maintenance therapy.

  Bipolar disorders 20050101

• Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review.

  CNS drugs 20050101

• Use of ziprasidone in parkinsonian patients with psychosis.

  Clinical neuropharmacology 20050101

• Ziprasidone for agitation or psychosis in dementia: four cases.

  International journal of psychiatry in medicine 20050101

• The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy.

  Medical hypotheses 20050101

• A typical mood stabilizers: a 'typical role for atypical antipsychotics.

  Acta psychiatrica Scandinavica. Supplementum 20050101

• Ziprasidone: from pharmacology to the clinical practice. One year of experience.

  Actas espanolas de psiquiatria 20050101

• Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source.

  Rapid communications in mass spectrometry : RCM 20050101

• Pharmacokinetics and therapeutics of acute intramuscular ziprasidone.

  Clinical pharmacokinetics 20050101

• Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study.

  Clinical neuropharmacology 20050101

• Ziprasidone and psychosis in Parkinson disease.

  Clinical neuropharmacology 20050101

• Ziprasidone overdose: cardiac safety.

  Actas espanolas de psiquiatria 20050101

• Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients.

  Clinical neuropharmacology 20050101

• Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.

  BMC medicine 20050101

• [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].

  Przeglad lekarski 20050101

• Pharmacology of antipsychotics in the elderly: a focus on atypicals.

  Journal of the American Geriatrics Society 20041201

• Optimizing atypical antipsychotic treatment strategies in the elderly.

  Journal of the American Geriatrics Society 20041201

• An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

  Controlled clinical trials 20041201

• Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.

  Progress in neuro-psychopharmacology & biological psychiatry 20041201

• Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.

  The Journal of clinical psychiatry 20041201

• [Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

• Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.

  European journal of pharmacology 20041128

• [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].

  Psychiatrische Praxis 20041101

• [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].

  Psychiatrische Praxis 20041101

• Ziprasidone: first year experience in a hospital setting.

  Journal of psychiatric practice 20041101

• Tardive dyskinesia in 2 patients treated with ziprasidone.

  Journal of psychiatry & neuroscience : JPN 20041101

• Acute dystonic reaction with moderate-dose ziprasidone.

  Journal of clinical psychopharmacology 20041001

• The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.

  Bipolar disorders 20041001

• Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.

  The American journal of psychiatry 20041001

• Prolactin elevation with ziprasidone.

  The American journal of psychiatry 20041001

• Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.

  CNS spectrums 20041001

• [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].

  Revista de neurologia 20041001

• The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.

  Postgraduate medicine 20041001

• Intravenous ziprasidone for treatment of delirium in the intensive care unit.

  Anesthesiology 20040901

• Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.

  The Journal of clinical psychiatry 20040901

• Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.

  The Journal of clinical psychiatry 20040901

• [Ziprasidone and dementia].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040826

• [Psychotropics and weight gain].

  Praxis 20040825

• Ziprasidone and mania.

  The American journal of psychiatry 20040801

• Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.

  Movement disorders : official journal of the Movement Disorder Society 20040801

• [Non-information from a drug industry].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040701

• [Ziprasidone-augmentation of clozapine].

  Psychiatrische Praxis 20040701

• Antipsychotic treatment of psychosis associated with multiple sclerosis.

  Progress in neuro-psychopharmacology & biological psychiatry 20040701

• The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.

  The Journal of clinical psychiatry 20040701

• Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.

  Clinical therapeutics 20040701

• No significant QTc interval changes with high-dose ziprasidone: a case series.

  Journal of psychiatric practice 20040701

• QTc prolongation in multiple drug overdose.

  Journal of clinical psychopharmacology 20040601

• Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.

  Human psychopharmacology 20040601

• Ziprasidone-induced lupus erythematosus.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040601

• Occupancy of agonist drugs at the 5-HT1A receptor.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040501

• Improvement in prosocial functioning after a switch to ziprasidone treatment.

  CNS spectrums 20040501

• A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.

  The American journal of psychiatry 20040501

• Ziprasidone for sedation of the agitated ED patient.

  The American journal of emergency medicine 20040501

• Use of ziprasidone to treat bipolar-associated catatonia.

  Bipolar disorders 20040401

• Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.

  Human psychopharmacology 20040401

• Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.

  Biomedical chromatography : BMC 20040401

• The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

  The Journal of clinical psychiatry 20040401

• Atypical antipsychotics and diabetes mellitus.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20040401

• Ziprasidone and mania.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040401

• [Ziprasidone. A new second-generation antipsychotic agent].

  Ugeskrift for laeger 20040329

• Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.

  Psychopharmacology 20040301

• Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

  The American journal of psychiatry 20040301

• [Hypomania induced by Ziprasidone].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040301

• [Paralytic ileus during haloperidol therapy].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20040301

• Evaluating the reconstitution of intramuscular ziprasidone (Geodon) into solution.

  Annals of emergency medicine 20040301

• Ziprasidone: a novel psychotropic with unique properties.

  Expert review of neurotherapeutics 20040301

• Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.

  Current medicinal chemistry 20040201

• Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.

  Current medicinal chemistry 20040201

• New antipsychotics and schizophrenia: a review on efficacy and side effects.

  Current medicinal chemistry 20040201

• Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.

  The Journal of clinical psychiatry 20040201

• Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.

  Schizophrenia research 20040201

• Determination of plasma ziprasidone using liquid chromatography with fluorescence detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040125

• [Current pharmacotherapy of schizophrenia].

  Orvosi hetilap 20040118

• Ziprasidone-related tardive dyskinesia.

  The American journal of psychiatry 20040101

• The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.

  The Journal of clinical psychiatry 20040101

• Hypomanic episodes after receiving ziprasidone: an unintended 'on-off-on' course of treatment.

  The Journal of clinical psychiatry 20040101

• Ziprasidone in Parkinson's disease psychosis.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040101

• The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.

  International clinical psychopharmacology 20040101

• Atypical antipsychotics in the treatment of children and adolescents: clinical applications.

  The Journal of clinical psychiatry 20040101

• Ziprasidone treatment of two adolescents with psychosis.

  Journal of child and adolescent psychopharmacology 20040101

• The case for atypical antipsychotics in bipolar disorder.

  Perspectives in psychiatric care 20040101

• Atypical antipsychotics in the treatment of affective symptoms: a review.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.

  Journal of the American Medical Directors Association 20040101

• Ziprasidone and weight gain.

  Clinical neuropharmacology 20040101

• The utility of intramuscular ziprasidone in the management of acute psychotic agitation.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• Intramuscular ziprasidone for acute agitation in adolescents.

  Journal of child and adolescent psychopharmacology 20040101

• Ziprasidone monotherapy in pediatric bipolar disorder.

  Journal of child and adolescent psychopharmacology 20040101

• The use of two neuroleptics to treat bipolar illness in two children.

  Journal of child and adolescent psychopharmacology 20040101

• Intramuscular ziprasidone in youth: a retrospective chart review.

  Journal of child and adolescent psychopharmacology 20040101

• Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.

  Journal of clinical psychopharmacology 20031201

• Extrapyramidal symptoms in children on atypical antipsychotic drugs.

  Journal of clinical psychopharmacology 20031201

• Ziprasidone in Huntington's disease: the first case reports.

  Journal of psychopharmacology (Oxford, England) 20031201

• Ziprasidone--not an option for serotonin syndrome.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20031125

• Mania from dose-related ziprasidone augmentation of an SSRI.

  The Journal of clinical psychiatry 20031101

• Schizophrenia, VI: Treatments.

  The American journal of psychiatry 20031001

• Possible ziprasidone-induced mania.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030901

• Ziprasidone-induced oculogyric crisis.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030901

• Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.

  Bioorganic & medicinal chemistry letters 20030818

• Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.

  Psychopharmacology 20030801

• Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030801

• Side effects of ziprasidone.

  The American journal of psychiatry 20030701

• Antipsychotic medication and seizures: a review.

  Drugs of today (Barcelona, Spain : 1998) 20030701

• [Treatment of young people with atypical antipsychotic agents].

  Ugeskrift for laeger 20030602

• Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.

  Bipolar disorders 20030601

• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  The Journal of clinical psychiatry 20030601

• Ziprasidone metabolism, aldehyde oxidase, and clinical implications.

  Journal of clinical psychopharmacology 20030601

• Ziprasidone in autism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030601

• A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.

  Psychopharmacology 20030501

• Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

  The Journal of clinical psychiatry 20030501

• Psychic akathisia.

  Journal of clinical psychopharmacology 20030401

• Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

  The American journal of psychiatry 20030401

• A case series of ziprasidone overdoses.

  Veterinary and human toxicology 20030301

• The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

  Journal of psychopharmacology (Oxford, England) 20030301

• Mania associated with initiation of ziprasidone.

  The Journal of clinical psychiatry 20030301

• alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.

  European journal of pharmacology 20030221

• Ziprasidone augmentation of clozapine in 11 patients.

  The Journal of clinical psychiatry 20030201

• Ziprasidone-associated mania: a case series and review of the mechanism.

  Bipolar disorders 20030201

• Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.

  Journal of the National Medical Association 20030201

• Ziprasidone-associated galactorrhea in a female teenager.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030101

• Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.

  The Journal of clinical psychiatry 20030101

• Prolonged erections associated with ziprasidone treatment: a case report.

  The Journal of clinical psychiatry 20030101

• Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.

  Journal of toxicology. Clinical toxicology 20030101

• Ziprasidone in the management of schizophrenia : the QT interval issue in context.

  CNS drugs 20030101

• Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.

  Journal of toxicology. Clinical toxicology 20030101

• Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost.

  The Journal of international medical research 20030101

• Ziprasidone-induced Pisa syndrome after clozapine treatment.

  The Journal of neuropsychiatry and clinical neurosciences 20030101

• Similarities and differences among antipsychotics.

  The Journal of clinical psychiatry 20030101

• Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.

  The Journal of clinical psychiatry 20030101

• The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.

  The Journal of clinical psychiatry 20030101

• Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.

  The Journal of clinical psychiatry 20030101

• Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials.

  The Journal of clinical psychiatry 20030101

• Maintaining symptom control: review of ziprasidone long-term efficacy data.

  The Journal of clinical psychiatry 20030101

• Ziprasidone and cognition: the evolving story.

  The Journal of clinical psychiatry 20030101

• Tolerability of ziprasidone: an expanding perspective.

  The Journal of clinical psychiatry 20030101

• Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.

  Journal of child and adolescent psychopharmacology 20030101

• Neuroleptic Malignant Syndrome with ziprasidone.

  Journal of clinical psychopharmacology 20021201

• Recent developments in pharmacotherapy for the acutely psychotic patient.

  Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20021201

• A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.

  The Journal of clinical psychiatry 20021201

• A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.

  International clinical psychopharmacology 20020901

• Ziprasidone alternative for olanzapine-induced hyperglycemia.

  The American journal of psychiatry 20020901

• Continuum of care: stabilizing the acutely agitated patient.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901

• Ziprasidone and migraine headache.

  The American journal of psychiatry 20020801

• Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.

  The American journal of psychiatry 20020801

• Tardive dyskinesia and ziprasidone.

  The American journal of psychiatry 20020801

• Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020801

• Priapism associated with two atypical antipsychotic agents.

  Pharmacotherapy 20020801

• Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.

  Psychopharmacology 20020701

• The value of atypical antipsychotics in the treatment of schizophrenia.

  Managed care (Langhorne, Pa.) 20020701

• Brief report on Ziprasidone.

  Mymensingh medical journal : MMJ 20020701

• Overdose of ziprasidone.

  The American journal of psychiatry 20020601

• Prolongation of QTc interval and antipsychotics.

  The American journal of psychiatry 20020601

• A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.

  The Journal of clinical psychiatry 20020601

• [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].

  MMW Fortschritte der Medizin 20020506

• Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501

• Ziprasidone: the fifth atypical antipsychotic.

  The Annals of pharmacotherapy 20020501

• Experience with ziprasidone.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020501

• The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.

  Journal of clinical psychopharmacology 20020401

• Ziprasidone induction of hypomania in depression?

  The American journal of psychiatry 20020401

• Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020301

• Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients.

  Journal of psychiatric research 20020101

• Ziprasidone hydrochloride.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020101

• Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.

  Clinical therapeutics 20020101

• Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.

  The Journal of clinical psychiatry 20020101

• Ziprasidone treatment of delirium.

  Psychosomatics 20020101

• Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.

  CNS drugs 20020101

• Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.

  Drugs 20020101

• The role of atypical antipsychotics in the treatment of delirium.

  Psychosomatics 20020101

• Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.

  CNS drugs 20020101

• New drugs 2002, part 1.

  Nursing 20020101

• [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].

  Medicina (Kaunas, Lithuania) 20020101

• Comparing the side effect profile of the atypical antipsychotics.

  West African journal of medicine 20020101

• Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.

  European journal of pharmacology 20011005

• Ziprasidone: profile on safety.

  Expert opinion on pharmacotherapy 20011001

• Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

  European journal of pharmacology 20010817

• Use of atypical antipsychotics in mood disorders.

  Current opinion in investigational drugs (London, England : 2000) 20010701

• Ziprasidone (Geodon) for schizophrenia.

  The Medical letter on drugs and therapeutics 20010611

• Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.

  Neuropharmacology 20010601

• Ziprasidone, a new atypical antipsychotic drug.

  Pharmacotherapy 20010601

• Ziprasidone approved.

  The Harvard mental health letter 20010601

• Ziprasidone: a new atypical antipsychotic.

  Expert opinion on pharmacotherapy 20010601

• Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warning.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010501

• Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.

  Psychopharmacology 20010501

• The apparent effects of ziprasidone on plasma lipids and glucose.

  The Journal of clinical psychiatry 20010501

• Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.

  Journal of clinical psychopharmacology 20010201

• Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.

  Annual review of medicine 20010101

• Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

  The Journal of clinical psychiatry 20010101

• Sustaining short-term gains for future progress.

  International clinical psychopharmacology 20010101

• The pharmacology of weight gain with antipsychotics.

  The Journal of clinical psychiatry 20010101

• Psychopharmacology news.

  Journal of child and adolescent psychopharmacology 20010101

• New schizophrenia drug.

  FDA consumer 20010101

• Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone.

  Pharmacology, biochemistry, and behavior 20010101

• Review of atypical antipsychotics and weight gain.

  The Journal of clinical psychiatry 20010101

• Med-psych drug-drug interactions update.

  Psychosomatics 20010101

• Focus on ziprasidone.

  Current medical research and opinion 20010101

• Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.

  Psychopharmacology bulletin 20010101

• Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

  The Journal of pharmacology and experimental therapeutics 19951001